What Happened to Centers for Disease Control and Prevention (CDC)?
The Centers for Disease Control and Prevention (CDC), the leading U.S. public health agency, has faced significant challenges and undergone substantial leadership changes and reforms since 2020, particularly in the wake of the COVID-19 pandemic. While striving to modernize its data infrastructure and improve emergency response, the agency has also navigated intense political scrutiny, budget debates, and controversies surrounding vaccine policies and scientific communication, leading to a period of instability in its top leadership. As of late 2026, the CDC is under new permanent leadership and continues to address ongoing public health threats while working to rebuild public trust and enhance its readiness for future crises.
Quick Answer
The Centers for Disease Control and Prevention (CDC) has experienced a tumultuous period since 2020, marked by its central role in the COVID-19 pandemic response, subsequent criticisms, and a rapid succession of directors. The agency has focused on modernizing its data systems and improving its communication strategies to restore public trust. However, it has also faced political interference, budget pressures, and controversial changes to vaccine recommendations. As of September 2026, Erica Schwartz has been confirmed as the new permanent director, inheriting an agency grappling with ongoing outbreaks, a revised childhood immunization schedule, and efforts to redefine its core mission amidst continued political scrutiny.
📊Key Facts
📅Complete Timeline14 events
Initial COVID-19 Response Challenges
The CDC faced significant criticism for its initial handling of the COVID-19 pandemic, including issues with testing availability, data collection, and inconsistent public health messaging, leading to a decline in public trust.
Dr. Rochelle Walensky Appointed Director
Dr. Rochelle Walensky was appointed as the 19th Director of the CDC by President Joe Biden, tasked with rebuilding the agency's scientific credibility and public trust after the Trump administration.
Dr. Walensky Resigns, Dr. Mandy Cohen Appointed
Dr. Rochelle Walensky resigned as CDC Director. President Biden subsequently appointed Dr. Mandy Cohen, former North Carolina Health Secretary, as the 20th Director, with a focus on modernization and pandemic preparedness.
Launch of Public Health Data Strategy (PHDS)
The CDC launched its Public Health Data Strategy (PHDS) to modernize the nation's public health data infrastructure, aiming for faster, more complete, and secure data exchange to respond to health threats.
Dr. Mandy Cohen's Tenure Ends, Susan Monarez Appointed
Dr. Mandy Cohen concluded her term as CDC Director. Susan Monarez was appointed as her successor, but her tenure was short-lived.
Director Susan Monarez Fired Amidst Controversy
CDC Director Susan Monarez was fired after less than a month in office, reportedly due to conflicts with HHS Secretary Robert F. Kennedy Jr. over vaccine policy and her refusal to dismiss career officials.
Presidential Memorandum on Childhood Immunization Schedule
President Trump issued a Presidential Memorandum directing HHS and CDC to review international best practices for childhood vaccination schedules and update the U.S. schedule if superior approaches exist.
Revised Childhood Immunization Schedule Recommended
Acting CDC Director Jim O'Neill formally accepted recommendations to revise the U.S. childhood and adolescent immunization schedule, decreasing the number of universally recommended vaccines and emphasizing shared clinical decision-making.
Congressional Budget for FY26 Passed
Despite the President's Budget proposing significant cuts, Congress passed a budget for FY26 that included mostly level funding for the CDC, indicating a divergence in priorities.
Erica Schwartz Nominated as CDC Director
President Trump nominated Erica Schwartz, a former deputy surgeon general, as the next permanent director of the CDC, following a period of acting leadership.
Blocked COVID-19 Vaccine Study Published Externally
A COVID-19 vaccine efficacy study, previously blocked by acting CDC Director Jay Bhattacharya from appearing in the CDC's own journal, was published in JAMA Network Open, affirming vaccine effectiveness.
Erica Schwartz Confirmed as CDC Director
The U.S. Senate confirmed Erica Schwartz as the permanent Director of the CDC, ending a nearly year-long leadership vacuum and a series of acting directors.
New Overdose Prevention Data Channel Launched
The CDC launched a new Overdose Prevention Data Channel, a centralized web page providing national drug overdose numbers, prevention tips, and treatment resources.
Controversy Over Pennsylvania Measles Deaths
The CDC faced controversy for excluding two measles-related deaths reported by the Pennsylvania Department of Health from its national tally, citing a review of additional information.
Follow this story
Get an email when this timeline gets a major update.
🔍Deep Dive Analysis
The Centers for Disease Control and Prevention (CDC), America's foremost public health agency, has been at the epicenter of national and global health crises, particularly since the onset of the COVID-19 pandemic in 2020. Initially lauded for its scientific expertise, the agency faced unprecedented scrutiny and criticism for its early pandemic response, including issues with testing rollout, inconsistent messaging, and perceived political interference under the Trump administration. This period led to a significant erosion of public trust and calls for comprehensive reform (Source: PMC, 2021; The Heritage Foundation, 2025).
In response to these challenges, the CDC, under former Director Rochelle Walensky (2021-2023), initiated a major overhaul aimed at improving data collection, streamlining communication, and enhancing its rapid response capabilities. These efforts included the launch of the Public Health Data Strategy (PHDS) in 2023, with annual updates focusing on strengthening core data sources, accelerating access to analytic solutions, and advancing interoperability across the public health ecosystem (Source: HLN Consulting, 2026; CDC, 2026). However, the agency continued to grapple with the politicization of public health, particularly concerning vaccine guidance and mandates.
The period from 2023 to 2026 saw considerable leadership instability. Dr. Mandy Cohen took over as Director in July 2023, focusing on embedding lessons from the pandemic and investing in core public health capabilities like workforce, laboratories, and data systems. Her tenure ended in January 2025. She was succeeded by Susan Monarez, who served for less than a month before being fired in August 2025 amid conflicts with Health and Human Services (HHS) Secretary Robert F. Kennedy Jr. over vaccine policy (Source: Medical Economics, 2025; FirstWord Pharma, 2026). This marked the beginning of a rapid succession of acting directors, including Jim O'Neill and Jay Bhattacharya, who faced their own controversies, such as the blocking of a COVID-19 vaccine efficacy study from the CDC's own journal (Source: Healthline, 2026; Washington Post, 2026).
As of August 2026, Erica Schwartz was confirmed as the new permanent Director, bringing a background as a former deputy surgeon general. Her appointment comes at a time when the CDC is navigating significant policy shifts, including a revised childhood immunization schedule that recommends fewer universal vaccines and emphasizes shared clinical decision-making (Source: FirstWord Pharma, 2026; Primary Care Alliance, 2026). This change, driven by a Presidential Memorandum in late 2025, aims to align U.S. practices with international consensus and rebuild public trust, though it has also sparked debate (Source: CDC, 2026; MissPoppins, 2026).
Currently, the CDC is focused on its 2026 priorities, which include enhancing emerging infectious disease readiness, establishing a sustainable wastewater surveillance network, protecting against antimicrobial resistance, and strengthening the U.S. Port Health Protection System (Source: CDC, 2026). The agency is also actively responding to ongoing outbreaks, such as a measles outbreak in Pennsylvania, which has seen controversy over the CDC's handling of reported deaths (Source: Pittsburgh Post-Gazette, 2026; The Guardian, 2026). Budget proposals from the Trump administration for fiscal years 2026 and 2027 seek to narrow the CDC's mission to core infectious disease functions and reduce its workforce, setting up potential clashes with Congress over the agency's future scope and funding (Source: Legis1, 2026). The agency also launched a new Overdose Prevention Data Channel in September 2026, providing a centralized resource for overdose trends and prevention (Source: HealthDay, 2026).
What If...?
Explore alternate histories. What if Centers for Disease Control and Prevention (CDC) made different choices?